一种用于经心尖途径主动脉瓣、二尖瓣及各段主动脉的新型实验装置
一种用于经心尖途径主动脉瓣和二尖瓣介入治疗的新型实验装置CorPoint,在猪模型中验证了其减少出血和并发症的效果。

基本信息
资源简介
一种用于经心尖途径主动脉瓣、二尖瓣及各段主动脉的新型实验装置
【一句话概览】
本数据集是 figshare 公开的文本数据集,收录 7 个文件、合计 998.11 KB,主题涵盖 Models, Animal、Hemorragia、Endovascular Procedures、Stents、Minimally Invasive Surgical Procedures,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《A New Experimental Device for Transapical Access of the Aortic and Mitral Valves as well as the Aorta in its Various Segments》。配套论文《A New Experimental Device for Transapical Access of the Aortic and Mitral Valves as well as the Aorta in its Various Segments》发表于 Brazilian Journal of Cardiovascular Surgery(2017),DOI:10.21470/1678-9741-2017-0013。源站首次发布:2017-12-05。
【数据内容】
源站原始描述:Abstract Objective: To present the results of a new experimental device developed to facilitate the transapical access in endovascular treatment of structural heart diseases. It aims to reduce the risk of bleeding and complications in this type of access and demonstrate the device as a safe, fast and effective alternative. Methods: CorPoint is composed of three parts: introducer, base with coiled spring, and closing capsule. By rotating movements, the spring is introduced into the myocardium and…
中文译文(机器翻译,仅供快速理解,请以原文为准):摘要 目的:介绍一种新实验装置的结果,该装置为促进结构性心脏病血管内治疗中的经心尖入路而开发。其旨在降低此类入路的出血和并发症风险,并证明该装置是一种安全、快速且有效的替代方案。 方法:CorPoint由三部分组成:导入器、带螺旋弹簧的底座
【数据结构与技术规格】
文件数 7 个,合计 998.11 KB。数据集 DOI:10.6084/m9.figshare.5670589.v1。
【主题与分类】
源站学科分类:Cardiology、Surgery。主题标签:Models, Animal、Hemorragia、Endovascular Procedures、Stents、Minimally Invasive Surgical Procedures。
【适用方向】
文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面:https://scielo.figshare.com/articles/dataset/A_New_Experimental_Device_for_Transapical_Access_of_the_Aortic_and_Mitral_Valves_as_well_as_the_Aorta_in_its_Various_Segments/5670589
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Paim, Leonardo; Fonseca, José Honório Palma da; Arruda Junior, Francismar Vidal de; Sampaio Gutierrez, Paulo; Moreira, Luiz Felipe Pinho; Jatene, Fabio Biscegli (2017). A New Experimental Device for Transapical Access of the Aortic and Mitral Valves as well as the Aorta in its Various Segments. SciE…
【使用注意】
· 源站最后修改于 2023-05-30,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:A New Experimental Device for Transapical Access of the Aortic and Mitral Valves as well as the Aorta in its Various Segments
- DOI:10.6084/m9.figshare.5670589.v1
- 发布日期:2017-12-05
- 文件数:7 个
- 文件总体积:998.11 KB
- 源站页面:https://scielo.figshare.com/articles/dataset/A_New_Experimental_Device_for_Transapical_Access_of_the_Aortic_and_Mitral_Valves_as_well_as_the_Aorta_in_its_Various_Segments/5670589
命令行下载
curl -L -o "0102-7638-rbccv-32-03-0156-gf01.jpg" "https://ndownloader.figshare.com/files/9912358"
curl -L -o "0102-7638-rbccv-32-03-0156-gf02.jpg" "https://ndownloader.figshare.com/files/9912361"
curl -L -o "0102-7638-rbccv-32-03-0156-gf03.jpg" "https://ndownloader.figshare.com/files/9912364"
curl -L -o "0102-7638-rbccv-32-03-0156-gf04.jpg" "https://ndownloader.figshare.com/files/9912367"
curl -L -o "0102-7638-rbccv-32-03-0156-gf05.jpg" "https://ndownloader.figshare.com/files/9912370"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/9912373"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/9912376"
文件清单
0102-7638-rbccv-32-03-0156-gf01.jpg(394.50 KB)0102-7638-rbccv-32-03-0156-gf02.jpg(189.75 KB)0102-7638-rbccv-32-03-0156-gf03.jpg(69.58 KB)0102-7638-rbccv-32-03-0156-gf04.jpg(40.29 KB)0102-7638-rbccv-32-03-0156-gf05.jpg(292.74 KB)Table_1.xls(5.63 KB)Table_2.xls(5.63 KB)
文件总体积 998.11 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Abstract Objective: To present the results of a new experimental device developed to facilitate the transapical access in endovascular treatment of structural heart diseases. It aims to reduce the risk of bleeding and complications in this type of access and demonstrate the device as a safe, fast and effective alternative. Methods: CorPoint is composed of three parts: introducer, base with coiled spring, and closing capsule. By rotating movements, the spring is introduced into the myocardium and progressively approaches the base to the surface of the heart. Guidewires and catheters are inserted through the hollow central part and, at the end of the procedure, the capsule is screwed over the base, therefore stopping any bleeding. Results: The device was implanted in 15 pigs, weighing 60 kg each, through an anterolateral thoracotomy, while catheters were introduced and guided by fluoroscopy. All animals had minimal bleeding; introducers with diameter up to 22 Fr were used and various catheters and guidewires were easily handled. After finishing the procedure, the closing capsule was attached and no bleeding was observed at the site. Conclusion: This new device has proved effective, fast and secure for the transapical access. This shows great potential for use, especially by ensuring an easier and direct access to the mitral and aortic valves; the shortest distance to be traveled by catheters; access to the ascending and descending aorta; decreased bleeding complications; decreased surgical time; and the possibility of allowing the technique to evolve and become totally percutaneous.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.5670589.v1(source: https://scielo.figshare.com/articles/dataset/A_New_Experimental_Device_for_Transapical_Access_of_the_Aortic_and_Mitral_Valves_as_well_as_the_Aorta_in_its_Various_Segments/5670589)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




